nebivolol
- Product NDC
- 24689-159
- 11-digit product format
- 246890159
- Labeler code
- 24689
- Product ID
- 24689-159_ffc06b5e-4f7d-4020-8be9-a4e903c1bfa8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- nebivolol hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Apnar Pharma LP
- Application
- ANDA216568
- Marketing category
- ANDA
- Marketing start
- 2024-05-13
- Substance
- NEBIVOLOL HYDROCHLORIDE
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Adrenergic beta-Antagonists [MoA], beta-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- nebivolol
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NEBIVOLOL HYDROCHLORIDE | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | JGS34J7L9I |
| Rxcui | 387013, 751612, 751618, 827073 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 24689-159-01 | nebivolol | 30 in 1 BOTTLE | TABLET | 30 | | 4 |
| 24689-159-02 | nebivolol | 90 in 1 BOTTLE | TABLET | 90 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 24689-159 | NEBIVOLOL (NEBIVOLOL HYDROCHLORIDE) TABLET [APNAR PHARMA LP] | 4 | Current NDC, 2 package rows | 20250226_3f5766c0-e1fa-4805-a32c-523182310ad5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 24689-159-01 | 24689015901 | 30 TABLET in 1 BOTTLE (24689-159-01) | 30 tablet | 2024-05-13 | No | No | Current |
| 24689-159-02 | 24689015902 | 90 TABLET in 1 BOTTLE (24689-159-02) | 90 tablet | 2024-05-13 | No | No | Current |